1 of 19

Pediatrics Journal Club Guide

2 of 19

Goals of Journal Club

  • Develop skills in designing studies
  • Practice analyzing an abstract in a structured way
  • Exposure to landmark papers, historical articles, and new literature
  • Participation in discussion!

3 of 19

Expectations for Journal Club

Participants

  • Show up!
  • Participate in small groups
  • Share ideas

Presenters

  • Select article
  • Prepare 6-7 slides to present
    • Research question
    • Causal hypothesis
    • Findings
    • Clinical implications
    • Next study

4 of 19

Structure

  • Presenters work in pairs
  • Each pair of presenters presents 1 paper
  • Ideally 2 groups of participants discuss each research question and develop a proposed study design

8:00 - 8:10

Each pair of presenters presents the brief background and research question being addressed by their paper

8:10 - 8:20

Breakout groups use the template to compose a causal hypothesis. Goal is to develop a study to answer the research question

8:20 - 8:30

Each group presents their study design and answers (~2 min per group)

8:30 - 9:00

Leaders discuss structure of the study. Discussion of differences, strengths, weaknesses, and clinical application

5 of 19

Causal Hypothesis

  • “study purpose” or “causal hypothesis” = the causal relationship that the authors originally intended to study and how they actually studied it

  • Identify key aspects of the study design just by reading the abstract
    • Quickly understand the purpose and design of the study
    • Read the rest of the article with focus
    • Critically assess the results within the context of the study design
    • Did the authors adequately study what they intended to?

Content adapted from CTS601A, Dr. William Jesdale

6 of 19

Vocabulary

Exposure Outcome, in Context

  • Study design: type of study
  • Exposure: independent variable; the “cause” of what you are studying
  • Exposure Contrast: reference group; compared to what alternative
  • Etiologic Period: when does exposure have an influence on disease, when exposure matters
  • Causal Direction: the impact/effect
  • Outcome: what you are measuring/studying
  • Outcome Contrast: compared to what alternative; “null hypothesis”
  • Population Context: In what population(s) is this relationship expected to be causal?; when, where, and in whom

7 of 19

Components of a Causal Hypothesis

Exposure Outcome, in Context

Conceptual definition: What is the idea? (intention)

Operational realization: How does a given person get assigned an exposure status? An outcome status? Included in study population? (actual)

    • What are the gaps between the conceptual definition and operational definition 🡪 leads to better understanding of the context for interpreting the results of the study
    • Can the results and clinical implications be expanded beyond the context of the study?

Content adapted from CTS601A, Dr. William Jesdale

8 of 19

Study Design

(Type of study)

Exposure

(Independent variable - the “cause” of what you are studying)

Conceptually:

Operationally:

Exposure Contrast

(Reference group - compared to what alternative)

Conceptually:

Operationally:

Etiologic Period

(Time period of reference)

Causal Direction

(Effect)

Outcome

(Dependent variable - What you are measuring)

Conceptually:

Operationally:

Outcome Contrast

(“Null hypothesis”)

Conceptually:

Operationally:

Population Context

(Who, when, where)

Conceptually:

Operationally:

9 of 19

Types of Study Designs

  • Meta-Analysis: combining data from many different research studies
  • Systematic Review: A summary of the clinical literature
  • Randomized Controlled Trial: A controlled clinical trial that randomly (by chance) assigns participants to two or more groups
  • Cohort Study (Prospective Observational Study): A clinical research study in which people who presently have a certain condition or receive a particular treatment are followed over time and compared with another group of people who are not affected by the condition
  • Case-control Study: Case-control studies begin with the outcomes and do not follow people over time. Researchers choose people with a particular result (the cases) and interview the groups or check their records to ascertain what different experiences they had
  • Cross-sectional study: Observation of a defined population at a single point in time or time interval. Exposure and outcome are determined simultaneously
  • Case Reports and Series: A report on a series of patients with an outcome of interest. No control group is involved

10 of 19

Cheat Sheet

Study Design

Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series

Exposure

“Cause” of what you are studying - medication, intervention, exposure etc.

Exposure Contrast

Compared to what alternative - placebo, unexposed, alternate med/dose, etc.

Etiologic Period

During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc.

Causal Direction

Effect - improves, worsens, increases, decreases, etc.

Outcome

What you are measuring – cancer, happiness, IQ score, etc.

Outcome Contrast

Absence of outcome – no cancer dx, etc

Population Context

Who, when, where - residents in Worcester, MA, etc.

11 of 19

Example of Journal Club Presentation

12 of 19

Background and Research Question

Background: Asthma is a common chronic condition among pediatric patients and is a common cause for presentation to the ED. Short-acting beta(2)-agonists are used to treat asthma symptoms. There are multiple modes of delivery for the medication.

Research Question: Is breath-enhanced nebulizer effective for treating asthma in pediatrics patients?

13 of 19

Cheat Sheet

Study Design

Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series

Exposure

“Cause” of what you are studying - medication, intervention, exposure etc.

Exposure Contrast

Compared to what alternative - placebo, unexposed, alternate med/dose, etc.

Etiologic Period

During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc.

Causal Direction

Effect - improves, worsens, increases, decreases, etc.

Outcome

What you are measuring – cancer, happiness, IQ score, etc.

Outcome Contrast

Absence of outcome – no cancer dx, etc

Population Context

Who, when, where - residents in Worcester, MA, etc.

14 of 19

Abstract

Exposure

Etiologic Period

Causal Direction

Outcome

Context

15 of 19

Identify components of the causal hypothesis

Study Design

(Type of study)

Randomized control trial

Exposure

(Independent variable - the “cause” of what you are studying)

Conceptually: breath-enhanced nebulizer treatment

Operationally: 5 mg albuterol delivered via breath-enhanced system

Exposure Contrast

(Reference group - compared to what)

Conceptually: conventional jet delivery nebulizer treatment

Operationally: 5 mg albuterol delivered via jet-delivery system

Etiologic Period

(Time period when exposure matters)

Conceptually: during acute asthma exacerbation

Operationally: initial FEV1 <70% of predicted

Causal Direction

(Effect)

increases

Outcome

(Dependent variable - What you are measuring)

Conceptually: change in respiratory function

Operationally: change in FEV1 (missing time frame! – how long after neb?!)

Outcome Contrast

(“Null hypothesis”)

Conceptually: no change in respiratory function

Operationally: no change in FEV1 (missing time frame! – how long after neb?!)

Population Context

(Who, when, where)

Conceptually: children with acute asthma exacerbation in the ED

Operationally: children 8-16 yo with moderate to severe acute asthma who presented to an urban ED during 20-month period from October 2015 to May 2017

16 of 19

Causal Hypothesis

Exposure Outcome, in Context

Breath-enhanced delivery of albuterol compared to conventional jet delivery administered during acute asthma exacerbation causes a greater increase in FEV1 among pediatric patients 6-18 years old with a history of moderate to severe asthma while in the Emergency Department

17 of 19

Results

  • Sample = 107 pediatric patients between 6-18 years old
  • Improvement in FEV1 was significantly greater with conventional jet nebulizer (mean ΔFEV1 +13.8% vs +9.1%, P = .04).
    • Spirometry is effort dependent and challenging to obtain accurate measurements
    • Is a change in FEV1 of 9.1% vs 13.8% CLINICALLY significant?
    • This is an objective outcome, but FEV1 is not used for clinical decision making in the ED
  • There were no significant differences in clinical asthma scores, ED length of stay, disposition, or side effects.
    • These were outcomes of clinical importance for providers in the ED
    • These were secondary outcomes in this study, so they may not have been powered to detect changes, but there was no trend observed either

18 of 19

Clinical Implications

  • Children who received conventional jet nebulizer treatments had statistically significantly more change in FEV1 than those who received breath-enhanced nebulizer treatments.
  • Despite greater change in FEV1, there were not differences in clinical symptoms or length of stay or disposition.

  • Based on this study, conventional jet nebulizers deliver albuterol “more effectively” than breath-enhanced nebulizers in pediatric patients
  • Not worth the investment of buying new machines for the pediatric ED to replace conventional jet nebulizers

19 of 19

Next Steps

  • Perform a similar RCT with larger sample size and multiple primary outcomes of clinical importance.

  • Perform a similar RCT with DuoNebs instead of albuterol

  • Perform a similar RCT, but measure outcome at 20 minutes after neb was completed rather than 10 minutes